Dr. Warren S. Goldstein, MD

Dr. Goldstein practices at ENT and Allergy Associates of Florida in Brooksville, Florida.

Dr. Goldstein's NPI, 1972530616, was assigned on June 27, 2006. Dr. Goldstein graduated from Lewis Katz School of Medicine in 1988. Dr. Goldstein holds Florida license ME56888.

Dr. Goldstein's primary practice is ENT and Allergy Associates of Florida, at 11373 Cortez Blvd, Brooksville, FL 34613 in Hernando County. The practice phone is (561) 338-3267.

Dr. Goldstein's primary practice is ENT and Allergy Associates of Florida in Brooksville, Florida. Dr. Goldstein is also affiliated with HCA Florida Oak Hill Hospital. The medical group on file is ENT & Allergy Associates of Florida. Dmand AI also links Dr. Goldstein to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goldstein practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Goldstein's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Goldstein is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Goldstein is licensed in Florida.

Dmand AI lists chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Goldstein treats.

CMS data shows 917 Medicare services from Dr. Goldstein across 11 procedure codes in 2024, for 382 Medicare patients. Medicare paid $74,068 for them. Every service was in an office.

CMS counts 382 Medicare patients who saw Dr. Goldstein in 2024. The largest group is 75 to 84, with 156 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Goldstein's median patient age at 71, with 51% women.

In 2024, Dr. Goldstein wrote 1,564 Medicare Part D claims for 550 patients. 98% of them were for generic drugs. CMS names the drug for 1,472 of them, across 17 drugs with 11 or more claims each, at $39,185 in total drug cost. In 2023, CMS named 965 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Goldstein for performance year 2024, reported individually. Dr. Goldstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Goldstein. Dr. Goldstein's most frequent co-authors are Roy R. Casiano, MD and Phillip Ruiz.

CMS Open Payments shows 64 general payments to Dr. Goldstein from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $234.

Dmand AI lists 3 awards for Dr. Goldstein, most recently CMS Stage 1 2012 in 2011.

Dr. Goldstein graduated from Lewis Katz School of Medicine in 1988. Dr. Goldstein is a member of NHS and ACS.

Dr. Goldstein is in network with 15 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.